St. ᅠJude Children’s Research Hospital received NCI comprehensive center designation
In 2008, the St.ᅠ Jude Children’s Research Hospital received National Cancer Institute (NCI) comprehensive center designation. St.ᅠJude Children’s…
In 2008, the St.ᅠ Jude Children’s Research Hospital received National Cancer Institute (NCI) comprehensive center designation. St.ᅠJude Children’s…
In 2008, Evestra was spun-off as a private biopharmaceutical company from the Texas Biomed Department of Organic Chemistry….
On Nov. 19, 2007, the University of California at San Francisco Cancer (UCSF) Research Institute was renamed the…
On Oct. 30, 2007, the Barnes-Jewish Hospital (BJC) Institute of Health at Washington University was established, to house…
on Oct. 15, 2007, the annual report from the National Cancer Institute (NCI) showed that cancer death rates…
On Oct. 9, 2007, the David H. Koch Institute for Integrative Cancer Research at MIT was established with…
On Oct. 2, 2007, the National Cancer Institute held a symposium to showcase several important historic achievements in…
On Sept. 23, 2007, the Stanford Cancer Institute (SCI) was awarded “cancer center” designation from the National Cancer…
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
On Jan. 12, 2007, the Gynecologic Cancer Education and Awareness Act of 2005′, or “Johanna’s Law’” (P.L. 109-475)…
In 2007, the U.S. Congress declared May National Cancer Control Month, an opportunity to educate all Americans about…
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
In 2007, Texans voted to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
On Mar. 22, 2006, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington School of Medicine in St….
On Jan. 31, 2006, Dan Duncan, founder of Enterprise Partners, an energy company in Houston, announced a donation…
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…
In 2006, an estimated 20.8% (45.3 million) of U.S. adults were current cigarette smokers; of these, 80.1% (36.3…
In 2006, The Indiana University Cancer Center was renamed the Indiana University Melvin and Bren Simon Cancer Center….
On Dec. 13, 2005, the National Cancer Institute (NCI) and the National Human Genome Research Institute launched a…
On Dec. 1, 2005, the Barbara Ann Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively…
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…